We serve Chemical Name:Ethyl (E)-3-cyclohexyl-2-propenoate CAS:17343-88-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Ethyl (E)-3-cyclohexyl-2-propenoate
CAS.NO:17343-88-3
Synonyms:Ethyl (E)-3-cyclohexyl-2-propenoate
Molecular Formula:C11H18O2
Molecular Weight:182.25900
HS Code:2916209090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:246.4ºC at 760 mmHg
Density:1.019g/cm3
Index of Refraction:1.521
PSA:26.30000
Exact Mass:182.13100
LogP:2.68600
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Ethyl (E)-3-cyclohexyl-2-propenoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ethyl (E)-3-cyclohexyl-2-propenoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ethyl (E)-3-cyclohexyl-2-propenoate Use and application,Ethyl (E)-3-cyclohexyl-2-propenoate technical grade,usp/ep/jp grade.
Related News: Novartis and GSK carried out a swap of its vaccine and cancer drugs back in 2015. GSK paid $5.25 billion to Novartis for its vaccine business, and Novartis sent $16 billion for GSK’s oncology programs. Tafinlar and Mekinist had already been granted FDA approval at the time of that deal, and as a part of that deal, Novartis agreed to divest its own BRAF and MEK inhibitors to avoid creating a monopoly. PigMent Yellow 12 manufacturers With the chemical industry being one of the most polluting, global efforts are heavily focused on developing a more sustainable and greener footprint. N,N-diethyl-2-piperazin-1-ylpyridine-3-carboxamide suppliers Altogether, the IPO added $550 million to the family’s collective fortune, which now stands at an estimated $4.8 billion. 2-pentadecyloxirane vendor & factory Given ICER’s uncertainty regarding efgartigimod’s dosing and long-term benefits, the group said it’s moderately certain the drug can produce a “comparable, small or substantial net health benefit” in that same group of MG patients. ,With the chemical industry being one of the most polluting, global efforts are heavily focused on developing a more sustainable and greener footprint.